Medicenna Therapeutics Corp. (TSX:MDNA)
Canada · Delayed Price · Currency is CAD 0.8700
-0.0100 (-1.14%)
At close: Mar 3, 2026
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of CAD 72.58 million as of March 4, 2026. Its market cap has decreased by -29.71% in one year.
Market Cap
72.58M
Enterprise Value
62.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.87
Market Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has increased from 65.63M to 72.58M, an increase of 10.58%. That is a compound annual growth rate of 1.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 72.58M | -5.43% |
| Dec 31, 2025 | 76.75M | -40.53% |
| Dec 31, 2024 | 129.06M | 341.25% |
| Dec 29, 2023 | 29.25M | -34.38% |
| Dec 30, 2022 | 44.57M | -60.68% |
| Dec 31, 2021 | 113.36M | -62.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 150.46M |
| ME Therapeutics Holdings | 75.12M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 62.62M |
| MedMira | 48.82M |
| Sernova Biotherapeutics | 47.47M |
| Devonian Health Group | 38.03M |
| BriaCell Therapeutics | 37.78M |